Halaven Prices, Coupons, Copay Cards & Patient Assistance
Halaven (eribulin) is a member of the mitotic inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Metastatic, and Liposarcoma.
The cost for Halaven (1 mg/2 mL) intravenous solution is around $1,515 for a supply of 2 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Halaven is available. See eribulin prices (from $724.00 for 2 milliliters).
Halaven prices
Intravenous Solution
1 mg/2 mL
Halaven intravenous solution
from $1,515.20
for 2 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 2 milliliters | $757.60 | $1,515.20 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Halaven Coupons, Copay Cards and Rebates
Halaven offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Halaven $0 Co-Pay Program
Eligible commercially insured patients may pay as little as $0 per prescription with a maxium savings of $18,000 per year.
- Applies to:
- Halaven
- Number of uses:
- per prescription per year
Form more information phone: 855-347-2448 or Visit website
Patient Assistance & Copay Programs for Halaven
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Halaven (eribulin) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Eisai Assistance Program: Halaven
Eligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- The patient must also be residing in the US.
- Eligibility determined on a case-by-case basis. Insurance benefits, claims assistance and/or other reimbursement help is offered. If a patient has insurance and the medication is not covered, then they may still be eligible for some type of assistance. This program also provides copay assistance.
- Halaven (eribulin) Injection; IV
More information please phone: 866-613-4724 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Xeloda
Xeloda is used to treat breast and colorectal cancers. Learn about side effects, interactions and ...
Herceptin
Herceptin is used to treat patients with metastatic breast cancer. Learn about side effects ...
More about Halaven (eribulin)
- Check interactions
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: mitotic inhibitors
- Breastfeeding
- En español
